Çakan, E.; Lara, O.D.; Szymanowska, A.; Bayraktar, E.; Chavez-Reyes, A.; Lopez-Berestein, G.; Amero, P.; Rodriguez-Aguayo, C.
Therapeutic Antisense Oligonucleotides in Oncology: From Bench to Bedside. Cancers 2024, 16, 2940.
https://doi.org/10.3390/cancers16172940
AMA Style
Çakan E, Lara OD, Szymanowska A, Bayraktar E, Chavez-Reyes A, Lopez-Berestein G, Amero P, Rodriguez-Aguayo C.
Therapeutic Antisense Oligonucleotides in Oncology: From Bench to Bedside. Cancers. 2024; 16(17):2940.
https://doi.org/10.3390/cancers16172940
Chicago/Turabian Style
Çakan, Elif, Olivia D. Lara, Anna Szymanowska, Emine Bayraktar, Arturo Chavez-Reyes, Gabriel Lopez-Berestein, Paola Amero, and Cristian Rodriguez-Aguayo.
2024. "Therapeutic Antisense Oligonucleotides in Oncology: From Bench to Bedside" Cancers 16, no. 17: 2940.
https://doi.org/10.3390/cancers16172940
APA Style
Çakan, E., Lara, O. D., Szymanowska, A., Bayraktar, E., Chavez-Reyes, A., Lopez-Berestein, G., Amero, P., & Rodriguez-Aguayo, C.
(2024). Therapeutic Antisense Oligonucleotides in Oncology: From Bench to Bedside. Cancers, 16(17), 2940.
https://doi.org/10.3390/cancers16172940